Public consultation on interim decisions to amend the Poisons Standard - ACMS, ACCS & Joint ACMS-ACCS November 2024

Closed 4 Apr 2025

Opened 14 Mar 2025

Contact

Medicines Scheduling

1800 020 653

medicines.scheduling@health.gov.au

Feedback updated 30 May 2025

We asked

From 14 March 2025 to 4 April 2025, we sought submissions from the public on the Delegate’s interim decisions on substances previously discussed at the November 2024 meetings of the Advisory Committees on Medicines and Chemicals Scheduling. Respondents were given the choice to indicate their support or opposition to the proposed amendments using survey buttons, with or without a written submission.

You said

A total of 12 submissions were received through the consultation, 4 from individuals and 8 from organisations. A breakdown of the submissions can be found below.

ASTODRIMER SODIUM: 5 submissions were received, 2 in full support, and 3 were in opposition of the interim decision. All those in opposition provided written components.

ATROPA BELLADONNA: 4 submissions were received, 3 in full support and 1 in partial support of the interim decision. Of these, 2 in full support and the 1 in partial support provided written submissions.

ETHYLENE OXIDE, PROPYLENE OXIDE, EPICHLOROHYDRINE: 7 submissions were received, 1 in full support and 6 in opposition of the interim decision. All the 6 in opposition provided written components.

SYMPHYTUM OFFICINALIS (COMFREY): 7 submissions were received, 3 in full support and 4 were in opposition of the interim decision. Of these, 1 in support and all 4 in opposition provided written components.

We did

The Delegate considered all submissions prior to making the final decisions. The final decisions on the proposed amendments to the Poisons Standard were published on 19 May 2025.

 

 

Overview

Interim decisions regarding substances discussed at the expert advisory meetings. 

This consultation is for interim decisions made in relation to substances that were discussed at the NOVEMBER 2024 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Joint meeting of the ACMS and the Advisory Committee on Chemicals Scheduling (ACCS).

Kindly note that the interim decisions published below may differ from the initial proposal. Please read through the proposed interim decisions which can be accessed through the links below and are available on the consultation page for your convenience.

Once you are familiar with the interim decision, please provide your comments and votes in relation to the interim decision.

The closing date for this consultation is close of business 4 APRIL 2025. All submissions received by the deadline will be considered by the delegate before they make an interim decision.

The interim decisions under consultation are detailed in the Public notice of interim decisions NOVEMBER 2024 which can be accessed below: 

Substances for which public comment is sought:

ACMS

  • Atropa belladonna

JOINT ACCS-ACMS

  • Ethylene oxide, propylene oxide, epichlorohydrin
  • Astodrimer sodium
  • Symphytum officinalis (comfrey)

The interim decision for pyridoxine, pyridoxal or pyridoxamine (vitamin B6) is delayed and will be published at a future date.

What happens next

All public submissions will be published on the TGA website at public submissions on scheduling matters, unless marked confidential or indicated otherwise in the submission information (see Privacy and your Personal information).

Public submissions are an important part of the process for amending the Poison Standard, and are published on the TGA website using the consultation hub.  Submissions by the public may not reflect the views of the Department of Health and Aged Care or TGA.  Published submissions should not be taken as being endorsed by the Department or TGA.

Following consideration of public submissions received before the closing date and advice from the expert advisory committees, decisions on the proposed amendments are anticipated to be published as final decisions on the TGA website: Scheduling delegate's final decisions at a later date.

Audiences

  • Aboriginal and Torres Strait Islander People
  • Seniors
  • Men
  • Women
  • Carers and guardians
  • Families
  • Parents
  • Young people
  • Academics
  • Non-government organisations
  • State government agencies
  • Commonwealth agencies
  • Health professionals
  • Health workforce
  • General public
  • Community groups
  • Businesses
  • Contracted Service Providers
  • Aged care service providers
  • Aged care workforce
  • Aged care professionals
  • BPRU staff
  • Graduates
  • Online and Publications staff
  • Secretariat
  • PCCD
  • Health staff
  • HPRG (TGA) Staff
  • Prescription medicines
  • Complementary medicines
  • Over-the-counter medicines
  • Medical Devices & IVDs
  • Biologicals
  • Other